Repligen Corp (RGEN): Next-Year EPS Estimate 28.12%
As of 2026-11-12, Repligen Corp (RGEN) has a next-year EPS growth estimate of 28.12%. Featured in our EPS revision report on 2026-10-15.
On 2026-11-09, analyst consensus for RGEN's next-year EPS growth shifted from 28.14% to 28.12% — a negative change of 0.02 percentage points. The revised estimate has been sustained across 4 subsequent trading sessions. Current-year growth is projected at 21.28%.
What's Driving This
RGEN’s rise has been supported primarily
Generated 2026-11-03 from news as of 2026-11-03
Current Snapshot
- Sector
- Healthcare
- Industry
- Medical Instruments & Supplies
- EPS growth next year
- 28.12%
- EPS growth this year
- 21.28%
- EPS next quarter (est)
- $0.52
- Last price
- $166.52
EPS Revision History
| Date | EPS Next Y | EPS This Y | Next Q (est) | Price |
|---|---|---|---|---|
| 2026-11-12 | 28.12% | 21.28% | $0.52 | $166.52 |
| 2026-11-11 | 28.12% | 21.28% | $0.52 | $172.62 |
| 2026-11-10 | 28.12% | 21.28% | $0.52 | $173.98 |
| 2026-11-09 | 28.12% | 21.28% | $0.52 | $178.94 |
| 2026-11-07 | 28.14% | 21.26% | $0.52 | $173.49 |
| 2026-11-06 | 28.14% | 21.26% | $0.52 | $173.49 |
| 2026-11-05 | 28.14% | 21.26% | $0.52 | $168.48 |
| 2026-11-04 | 28.14% | 21.26% | $0.52 | $178.20 |
| 2026-11-03 | 28.50% | 21.25% | $0.52 | $178.27 |
| 2026-11-02 | 28.50% | 21.25% | $0.52 | $172.95 |
| 2026-10-31 | 28.50% | 21.25% | $0.52 | $176.94 |
| 2026-10-30 | 28.50% | 21.25% | $0.52 | $176.94 |
| 2026-10-29 | 28.50% | 21.25% | $0.52 | $188.64 |
| 2026-10-28 | 28.50% | 21.25% | $0.52 | $184.69 |
| 2026-10-27 | 29.23% | 20.47% | $0.54 | $175.80 |
| 2026-10-26 | 28.74% | 20.46% | $0.46 | $180.17 |
| 2026-10-23 | 28.74% | 20.46% | $0.46 | $176.93 |
| 2026-10-22 | 28.74% | 20.46% | $0.46 | $178.71 |
| 2026-10-21 | 28.74% | 20.46% | $0.46 | $180.01 |
| 2026-10-20 | 28.74% | 20.46% | $0.46 | $178.88 |
| 2026-10-19 | 28.74% | 20.46% | $0.46 | $176.43 |
| 2026-10-16 | 28.40% | 20.66% | $0.46 | $175.42 |
| 2026-10-15 | 28.40% | 20.66% | $0.46 | $184.17 |
| 2026-10-14 | 28.39% | 20.67% | $0.46 | $178.20 |
| 2026-10-13 | 28.58% | 20.68% | $0.46 | $175.42 |
| 2026-10-12 | 27.87% | 20.38% | $0.46 | $172.51 |
| 2026-10-11 | 27.87% | 20.38% | $0.46 | $173.88 |
| 2026-10-10 | 27.87% | 20.38% | $0.46 | $173.88 |
| 2026-10-09 | 27.87% | 20.38% | $0.46 | $173.88 |
| 2026-10-08 | 27.87% | 20.38% | $0.46 | $163.84 |
Reports Featuring RGEN
Recent News
- Repligen Beats And Raises Again, But BioLife Does The Heavy Lifting On Guidance While Filtration WeakensEarnings Whispers
- Repligen: Q3 Earnings SnapshotAssociated Press
- Repligen Reports Third Quarter 2026 Financial Results and Updates Full Year 2026 Financial GuidanceGlobeNewswire
- Repligen to Report Third Quarter 2026 Financial ResultsGlobeNewswire
- Repligen Corp (RGEN) Q2 2026 Earnings Call Highlights: Strong Growth and Raised Guidance Amidst ...GuruFocus.com
- Repligen Reports Q2 Revenue Growth and Raises Full-Year 2026 GuidanceInvestorsHub
- Repligen: Q2 Earnings SnapshotAssociated Press
- Repligen Reports Second Quarter 2026 Financial Results and Updates Full Year 2026 Financial GuidanceGlobeNewswire
- Repligen Opens European Training & Innovation Center in Breda, Expanding Global Customer Support NetworkGlobeNewswire
Screen Performance
Aggregate stats across all 2145 tickers our top-EPS-revision screen has flagged over the past 225 days.
- Median return since detection
- -2.9%
- % of tickers in the green
- 43%
- Median return on winners
- +22.8%
- Large revisions captured
- 2246
Past detection performance reflects the price change between when a ticker first entered our screen and the most recent observation. Not a forward-looking forecast.
Also Tracked by Our Screen
Frequently Asked Questions
What is Repligen Corp's next-year EPS growth estimate?▾
As of 2026-11-12, Repligen Corp (RGEN) has a next-year EPS growth estimate of 28.12%, based on analyst consensus.
When was the latest EPS estimate revision for RGEN?▾
The most recent revision occurred on 2026-11-09, when analysts adjusted the next-year EPS growth estimate from 28.14% to 28.12%.
What sector and industry does Repligen Corp belong to?▾
Repligen Corp operates in the Healthcare sector, specifically the Medical Instruments & Supplies industry.
How often is this EPS estimate data updated?▾
EPS revision data is refreshed daily from analyst consensus estimates. RGEN appears on this page because it was flagged by our daily top-EPS-revision-performer screen.
EPS revision data sourced from analyst consensus estimates, refreshed daily. Repligen Corp (RGEN) appears here because it was detected by our daily top-EPS-revision-performer screen.